Login

Michaela Larissa Lobo de Andrade

ORCID: 0000-0003-3120-7701
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5007387595
Research Areas
  • Complement system in diseases
  • Platelet Disorders and Treatments
  • Immune Cell Function and Interaction
  • Blood groups and transfusion
  • Renal Diseases and Glomerulopathies

Hospital Estadual Centra
 2025

 Caplacizumab Added to Plasma Exchange and Immunosuppression Accelerates Recovery and Improves Survival in Immune-Mediated TTP: an International Real-World Study of the IWG-TTP (The Capla 1000+Project)
OPENALEX - Publications 
Paul Coppo Michaël Bubenheim Y. Benhamou Linus A. Völker Paul Brinkkötter and 32 more Lucas Kühne Paul Knöbl María Eva Mingot‐Castellano Cristina Pascual Javier de la Rubia Julio del Río-Garma Shruti Chaturvedi Camila Masias Marshall Mazepa X. Long Zheng György Sinkovits Marienn Réti Christopher J. Patriquin Katerina Pavenski T Boechat João Samuel de Holanda Farias Eduardo Flávio Oliveira Ribeiro Michaela Larissa Lobo de Andrade Agnès Veyradier Bérangère S. Joly Rachid Bouzid Kazuya Sakai Masanori Matsumoto Pasquale Agosti Ilaria Mancini Flora Peyvandi Eleni Gavriilaki Matthew Stubbs Amjad Hmaid Spero R. Cataland Bernhard Lämmle Marie Scully

10.1055/s-0044-1801671 article EN Hämostaseologie 2025-02-01
 Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
OPENALEX - Publications 
Paul Coppo Michaël Bubenheim Y. Benhamou Linus Völker Paul Brinkkötter and 32 more Lucas Kühne Paul Knoebl María Eva Mingot‐Castellano Cristina Pascual Javier de la Rubia Julio del Río-Garma Shruti Chaturvedi Camila Masias Marshall Mazepa Xiaopu Zheng György Sinkovits Marienn Réti Christopher J. Patriquin Katerina Pavenski T Boechat João Samuel de Holanda Farias Eduardo Flávio Oliveira Ribeiro Michaela Larissa Lobo de Andrade Agnès Veyradier Bérangère S. Joly Raïda Bouzid Kazuya Sakai Masanori Matsumoto Pasquale Agosti Ilaria Mancini Flora Peyvandi Eleni Gavriilaki Matthew Stubbs Amjad Hmaid Spero R. Cataland Bernhard Lämmle Marie Scully

The anti-Von Willebrand Factor (VWF) nanobody caplacizumab is licensed for adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP) in association therapeutic plasma exchange (TPE) and immunosuppression. However, whether reduces mortality, its optimal timing of initiation, not completely settled. This international, multicenter retrospective cohort study recruited patients from 2018 until 2023 data collection took place January 1st to June 30th the participating centers. One...

10.1016/j.eclinm.2025.103168 article EN cc-by EClinicalMedicine 2025-04-01
 Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)
OPENALEX - Publications 
Paul Coppo Michaël Bubenheim Y. Benhamou Linus A. Voelker Paul T. Brinkkoetter and 33 more Lucas Kühne Paul Knoebl María Eva Mingot‐Castellano Maria Cristina Pascual Izquierdo Javier de la Rubia Julio del Río-Garma Shruti Chaturvedi Camila Masias Marshall Mazepa X. Long Zheng György Sinkovits Marienn Réti Christopher J. Patriquin Katerina Pavenski T Boechat João Samuel de Holanda Farias Eduardo Flávio Oliveira Ribeiro Michaela Larissa Lobo de Andrade Agnès Veyradier Bérangère S. Joly Raïda Bouzid Kazuya Sakai Masanori Matsumoto Ilaria Mancini Pasquale Agosti Flora Peyvandi Matthew Stubbs Amjad Hmaid Sobia Sharif Tina Dutt Spero R. Cataland Bernhard Lämmle Marie Scully

10.1182/blood-2023-179316 article EN Blood 2023-11-02
 Brazilian experience with caplacizumab in acquired thrombotic thrombocytopenic purpura: outcomes of the expanded access program
OPENALEX - Publications 
T Boechat João Samuel de Holanda Farias Eduardo Flávio Oliveira Ribeiro Michaela Larissa Lobo de Andrade

10.1007/s00277-023-05211-8 article EN Annals of Hematology 2023-04-13
 Caplacizumab Added to Plasma Exchange and Immunosuppression Accelerates Recovery and Improves Survival in Immune-Mediated TTP: An International Real-World Study of the IWG-TTP (The Capla 1000 Project)
OPENALEX - Publications 
Paul Coppo Michaël Bubenheim Y. Benhamou Linus A. Völker Paul T. Brinkkoetter and 32 more Lucas Kühne Paul Knoebl María Eva Mingot‐Castellano Cristina Pascual Javier de la Rubia Julio del Río-Garma Shruti Chaturvedi Camila Masias Marshall Mazepa Long Zheng György Sinkovits Marienn Réti Christopher J. Patriquin Katerina Pavenski T Boechat João Samuel de Holanda Farias Eduardo Flávio Oliveira Ribeiro Michaela Larissa Lobo de Andrade Agnès Veyradier Bérangère S. Joly Raïda Bouzid Kazuya Sakai Masanori Matsumoto Pasquale Agosti Ilaria Mancini Flora Peyvandi Eleni Gavriilaki Matthew C. Stubbs Amjad Hmaid Spero R. Cataland Bernhard Lämmle Marie Scully

10.2139/ssrn.4989207 preprint EN 2024-01-01
Coming Soon ...